AYOXXA Biosystems, an international biotech company based in Cologne (Germany), Boston (USA) and Singapore has developed LUNARIS™ a proprietary technology platform for multiplex protein analysis. Core to the cutting-edge system is a bead-based technology that yields 10,000-fold more data points than a classical immunoassay. Together with the lowest sample volume in multiplex protein analysis history, an increased assay robustness, high data throughput and readout with fluorescence technology, AYOXXA will innovate biomedical research, pharmacological screening and preclinical diagnostics development. Its „in-situ encoded bead array“-technology allows industry and university users to realize the full potential of proteomics reliably as well as resource and cost efficiently.
AYOXXA stands for leveraging success in proteomics.